Aging
Navigate
Research Paper|Volume 8, Issue 12|pp 3311—3320

Association between genetic variants in the XPG gene and gastric cancer risk in a Southern Chinese population

Rui-Xi Hua1,3, Zhen-Jian Zhuo4, Jinhong Zhu5, Dan-Hua Jiang6, Wen-Qiong Xue1, Shao-Dan Zhang1, Jiang-Bo Zhang1, Xi-Zhao Li1, Pei-Fen Zhang1, Wei-Hua Jia1, Guo-Ping Shen1,7, Jing He1,2
  • 1Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Department of Experimental Research, Collaborative Innovation Center for Cancer Medicine, Guangzhou 510060, Guangdong, China
  • 2Department of Pediatric Surgery, Guangzhou Institute of Pediatrics, Guangzhou Women and Children’s Medical Center, Guangzhou Medical University, Guangzhou 510623, Guangdong, China
  • 3Department of Oncology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou 510080, Guangdong, China
  • 4School of Chinese Medicine, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong 999077, China
  • 5Molecular Epidemiology Laboratory and Department of Laboratory Medicine, Harbin Medical University Cancer Hospital, Harbin 150040, Heilongjiang, China
  • 6Department of Medical Genetics, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou 510080,Guangdong, China
  • 7Department of Radiation Oncology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou 510080, Guangdong, China

* * Equal contribution

Received: September 27, 2016Accepted: November 21, 2016Published: December 6, 2016

Abstract

Xeroderma pigmentosum group G (XPG) recognizes and excises DNA damage on the 3’ side during the DNA repair process. Previous studies indicated that XPG gene polymorphisms may associate with gastric cancer susceptibility, but results were inconsistent. We evaluated the association of five potentially functional XPG polymorphisms (rs2094258 C>T, rs751402 C>T, rs2296147 T>C, rs1047768 T>C, and rs873601 G>A) with gastric cancer susceptibility in 1142 gastric cancer cases and 1173 controls. Odds ratios (ORs) and 95% confidence intervals (CIs) were calculated using logistic regression models. Overall, no significant association was detected between any of selected polymorphism and gastric cancer risk. However, we found that individuals carrying 3-4 risk genotypes were at significantly higher risk of gastric cancer than those with 0-2 risk genotypes (OR=1.32, 95% CI=1.04-1.68, P=0.021). The stratification analysis revealed that the cumulative effect of risk genotypes (3-4 vs. 0-2) on gastric cancer were more prominent among subgroups older than 58 years and men. In conclusion, our results indicated that none of the selected XPG polymorphism could significantly alter gastric cancer susceptibility alone. These polymorphisms might collectively confer increased gastric cancer susceptibility. These findings would be strengthened by larger prospective multicenter studies involving different ethnic populations.